-
Merck to buy Pandion for $1.9B for its immune modulators — Biden looking beyond Woodcock or Sharfstein for FDA commmisioner — Former AveXis execs launch gene therapy startup See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
Welcome to the JNJ Board
Discussion in 'Johnson & Johnson' started by cafead, Aug 22, 2002 at 11:19 AM.
Page 1 of 3
Page 1 of 3